Bioradiations Staff
Fatima Valdes Mora |
Xiaoti Guo |
| Presented by: |
Fatima Valdes Mora, PhD, Team Leader, Functional Cancer Epigenetic Biology and Therapeutics Group, Children’s Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Australia Xiaoti Guo, PhD, Senior Product Marketing Manager, Single-Cell Technologies, Bio-Rad Laboratories, Inc. |
|
Available on Demand |
|
The single-cell assay for transposase-accessible chromatin using sequencing (scATAC-seq) is a relatively new and powerful technique that allows researchers to identify open chromatin regions and provides insight into the regulation of gene expression in individual cells. It has proven to be valuable for the study of cancer cell heterogeneity, understanding the regulatory landscape of individual cells, and exploring the molecular mechanisms underlying development and disease progression.
This webinar focuses on scATAC-seq applications for deciphering pediatric cancer cell heterogeneity. Fatima Valdes Mora, PhD, at Children’s Cancer Institute, UNSW, discusses how she has utilized scATAC-seq to study childhood cancers and investigate mechanisms of chemotherapy resistance in leukemia cells, and shares tips and tricks for overcoming technical challenges associated with difficult samples in scATAC-seq workflows.
Watch this state-of-the-art webinar to learn how scATAC-seq analysis can expand and deliver greater insights to your cancer research.
Watch Webinar